Referencias bibliográficas

1. Mead PS. Epidemiology of Lyme disease. Infect Dis Clin North Am. 2015 Jun;29(2):187-210. [Pubmed]
2. Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. Lyme borreliosis: diagnosis and management. BMJ. 2020 May 26;369:m1041. [Pubmed]
3. Hercogova J, Brzonova I. Lyme disease in central Europe. Curr Opin Infect Dis. 2001 Apr;14(2):133-7. [Pubmed]
4. Marques AR, Strle F, Wormser GP. Comparison of Lyme Disease in the United States and Europe. Emerg Infect Dis. 2021 Aug;27(8):2017-24. [Pubmed]
5. Hubálek Z. Epidemiology of lyme borreliosis. Curr Probl Dermatol. 2009;37:31-50. [Pubmed]
6. Lindgren E, Jaenson T. Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures. World Health Organization; 2006. Disponible en: [Enlace]
7. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology. 2004;129 Suppl:S191-220. [Pubmed]
8. Ross Russell AL, Dryden MS, Pinto AA, Lovett JK. Lyme disease: diagnosis and management. Pract Neurol. 2018 Dec;18(6):455-64. [Pubmed]
9. Cardenas-de la Garza JA, De la Cruz-Valadez E, Ocampo-Candiani J, Welsh O. Clinical spectrum of Lyme disease. Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):201-8. [Pubmed]
10. Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015 Feb;57:82-115. [Pubmed]
11. Hu LT. Lyme Disease. Ann Intern Med. 2016 May 3;164(9):ITC65-ITC80. [Pubmed]
12. Vasudevan B, Chatterjee M. Lyme borreliosis and skin. Indian J Dermatol. 2013 May;58(3):167-74. [Pubmed]
13. Robinson ML, Kobayashi T, Higgins Y, Calkins H, Melia MT. Lyme carditis. Infect Dis Clin North Am. 2015 Jun;29(2):255-68. [Pubmed]
14. Marques AR. Lyme Neuroborreliosis. Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1729-44. [Pubmed]
15. Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am. 2015 Jun;29(2):241-53. [Pubmed]
16. Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015 Aug;11(8):446-56. [Pubmed]
17. Ogrinc K, Lusa L, Lotrič-Furlan S, Bogovič P, Stupica D, Cerar T, et al. Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory Findings. Clin Infect Dis. 2016 Aug 1;63(3):346-53. [Pubmed]
18. Zajkowska J, Garkowski A, Moniuszko A, Czupryna P, Ptaszyńska-Sarosiek I, Tarasów E, et al. Vasculitis and stroke due to Lyme neuroborreliosis - a review. Infect Dis (Lond). 2015 Jan;47(1):1-6. Erratum in: Infect Dis (Lond). 2015;47(10):754. [Pubmed]
19. Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, et al. Lyme borreliosis. Nat Rev Dis Primers. 2016 Dec 15;2:16090. Erratum in: Nat Rev Dis Primers. 2017 Aug 03;3:17062. [Pubmed]
20. Aucott JN. Posttreatment Lyme disease syndrome. Infect Dis Clin North Am. 2015 Jun;29(2):309-23. [Pubmed]
21. Centers for Disease Control and Prevention (CDC). MMWR Morbidity and mortality weekly report. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. CDC; 1995. Disponible en: [Enlace]
22. Shapiro ED. Clinical practice. Lyme disease. N Engl J Med. 2014 May 1;370(18):1724-31. [Pubmed]
23. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011 Jan;17(1):69-79. [Pubmed]
24. Thomas S. Structure-Based Design of Diagnostics and Vaccines for Lyme Disease. Methods Mol Biol. 2022;2410:411-22. [Pubmed]
25. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-73. [Pubmed]
26. Sarbu N, Shih RY, Jones RV, Horkayne-Szakaly I, Oleaga L, Smirniotopoulos JG. White Matter Diseases with Radiologic-Pathologic Correlation. Radiographics. 2016 Sep-Oct;36(5):1426-47. [Pubmed]
27. Garkowski A, Łebkowska U, Kubas B, Garkowska E, Rutka K, Gawarecka E, Zajkowska J. Imaging of Lyme Neuroborreliosis: A Pictorial Review. Open Forum Infect Dis. 2020 Aug 19;7(10):ofaa370. [Pubmed]
28. Agarwal R, Sze G. Neuro-lyme disease: MR imaging findings. Radiology. 2009 Oct;253(1):167-73. [Pubmed]
29. Cedeno F, Penalva de Oliveira AC, Vidal JE, Trujillo JR. Virus neurotrópicos: el virus JC y la leucoencefalopatía multifocal progresiva. Rev Mex Neuroci. 2006;7(1):46-54. Disponible en: [Enlace]
30. Guarnizo A, Bermúdez S, Torres Ó, Nassar A, Torres C. Diagnóstico y evaluación de la esclerosis múltiple: lo que el radiólogo debe conocer e informar. Conceptos actuales. Rev Colomb Radiol. 2016;27(4):4543-55. Disponible en: [Enlace]
31. Ropper AH. Neurosyphilis. N Engl J Med. 2019 Oct 3;381(14):1358-63. Erratum in: N Engl J Med. 2019 Oct 31;381(18):1789. [Pubmed]
32. He C, Kong Q, Shang X, Duan Y, Cui Y, Wang J, et al. Clinical, laboratory and brain Magnetic Resonance Imaging (MRI) characteristics of asymptomatic and symptomatic HIV-negative neurosyphilis patients. J Infect Chemother. 2021 Nov;27(11):1596-601. [Pubmed]
33. Núñez C, Verdugo R, Cartier L. Meningovasculitis luética de la médula espinal. Rev Chil Neuro-Psiquiat. 2009;47(2):138-43. Disponible en: [Enlace]
34. Román GC. Tropical myelopathies. Handb Clin Neurol. 2014;121:1521-48. [Pubmed]
35. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008 Nov;14(9):1157-74. [Pubmed]